Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Circulation. Cardiovascular Imaging
|
July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans
Jennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
Thorax
|
October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia
Thomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
Annals of Translational Medicine
|
August 15, 2020
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumonia
Thomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
The Lancet. Respiratory Medicine
|
December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation
Thomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Critical Care Medicine
|
January 5, 2021
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery
Allison Tong, Amanda Baumgart, Nicole Evangelidis, et al.
Nature Immunology
|
May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Nature Immunology
|
July 19, 2022
Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Nature Medicine
|
April 21, 2021
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson, Gary Reynolds, Rachel A Botting, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Circulation. Cardiovascular Imaging
|
July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans
Jennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
Thorax
|
October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia
Thomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
Annals of Translational Medicine
|
August 15, 2020
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumonia
Thomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
The Lancet. Respiratory Medicine
|
December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation
Thomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Critical Care Medicine
|
January 5, 2021
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery
Allison Tong, Amanda Baumgart, Nicole Evangelidis, et al.
Nature Immunology
|
May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Nature Immunology
|
July 19, 2022
Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Ananda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Nature Medicine
|
April 21, 2021
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson, Gary Reynolds, Rachel A Botting, et al.
Page
of 13